Kemnay Advisory Services’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$205K Buy
10,450
+2,492
+31% +$47.7K 0.02% 88
2026
Q2
$116K Buy
7,958
+1,089
+16% +$16.1K 0.01% 148
2026
Q1
$100K Buy
+6,869
New +$79.7K 0.02% 116

Other funds holding ANIK

Kemnay Advisory Services's ANIK Position: Q3 2026 in Review

Kemnay Advisory Services increased its Anika Therapeutics (ANIK) stake by 31% in Q3 2026, buying an estimated $47.7K and bringing the position to 10,450 shares worth $205K. The position accounts for 0.02% of the portfolio, ranked #88.

Kemnay Advisory Services first reported a position in ANIK in Q1 2026 and has held it in 3 quarters since. 138 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.

  • Kemnay Advisory Services held 10,450 shares of Anika Therapeutics worth $205K as of Q3 2026.
  • Kemnay Advisory Services bought 2,492 Anika Therapeutics shares in Q3 2026, an estimated $47.7K.
  • Anika Therapeutics made up 0.02% of Kemnay Advisory Services's portfolio in Q3 2026, its #88 holding.
  • Kemnay Advisory Services first reported a position in Anika Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 138 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.

Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.